PsyMaptic is a free online prediction tool for healthcare planners, commissioners and other key stakeholders who require accurate and reliable data on the expected incidence (new, clinically-relevant cases per year) of psychotic disorder in England & Wales. The tool gives instant access to the expected incidence of psychotic disorder in different regions of England & Wales, based on their sociodemographic and socioeconomic profile.
When using predictions from the tool, please be aware that our forecasts are based on the expected number of clinically-relevant cases of first episode psychosis occurring in each region per year. Actual demand for severe mental health care services, including early intervention services [EIS], will likely be higher than our predictions, given a degree of people who will consume service resources, and who may require some form of mental health care intervention, but who are not found to meet clinical criteria for severe mental illness.
You can find out more details about the project on these pages, including screenshots of the PsyMaptic tool, an overview of how we created the tool, and our user guide. A full description of our methodology is provided here. You can also sign up to our email list to be kept up-to-date about PsyMaptic progress, follow us on Twitter or visit our Facebook page.
This tool has been developed by Dr James B. Kirkbride of the EpiCentre group in the Department of Psychiatry, University of Cambridge. Funding for this project is made available by the Wellcome Trust, who provide PsyMaptic prediction data free-of-charge to end-user stakeholders.
The modelling process is based on estimates, which by their nature, contain a degree of imprecision. While the models have been validated in a second sample (SEPEA), each prediction point estimate will have a degree of imprecision which should be taken into account by people using this data. Users of this data should understand the nature of prediction models and forecasts and should take into account prediction error when using this data. We ask users of the data to read our disclaimer and to agree to our terms and conditions before using PsyMaptic.